Abstract

RATIONALE: The ability of CD40 signaling to regulate B cell growth, survival, differentiation, and Ig class switching involves changes in gene expression. CD40 ligation activates the Rel/NF-κB transcription factors, which are major regulators of immune and inflammatory responses and potentially activates both type 1 (p105/p50) and type 2 (p100/p52) NF-κB activation pathways. Using primary B cells, we investigated the contribution of NFκb activation on CD40 mediated IL-13 receptor expression, using BAY11, an IkappaB-alpha phosphorylation inhibitor.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call